Molecular Mechanisms of FLASH Radiotherapy in Alleviating Lung Normal Tissue Injury: Insights from Single-Cell Sequencing.
FLASH radiotherapy (FLASH-RT), with its ultra-high dose rate (≥40 Gy/s) that causes the "FLASH effect," significantly reduces normal tissue toxicity while maintaining tumor cytotoxicity, but its molec
APA
Guo Z, Luo Y, Wang J (2026). Molecular Mechanisms of FLASH Radiotherapy in Alleviating Lung Normal Tissue Injury: Insights from Single-Cell Sequencing.. Radiation research, 205(4), 374-385. https://doi.org/10.1667/RADE-25-00125
MLA
Guo Z, et al.. "Molecular Mechanisms of FLASH Radiotherapy in Alleviating Lung Normal Tissue Injury: Insights from Single-Cell Sequencing.." Radiation research, vol. 205, no. 4, 2026, pp. 374-385.
PMID
41679749
Abstract
FLASH radiotherapy (FLASH-RT), with its ultra-high dose rate (≥40 Gy/s) that causes the "FLASH effect," significantly reduces normal tissue toxicity while maintaining tumor cytotoxicity, but its molecular mechanisms have not been fully elucidated. Previous studies have identified a protective mitochondrial homeostasis mechanism in normal cells during proton FLASH-RT. To further investigate this mechanism, we used an orthotopic lung cancer mouse model to compare the effects of FLASH-RT with conventional radiotherapy and employed single-cell sequencing to comprehensively analyze differences in single-cell gene expression profiles between normal lung tissue and tumors after irradiation. The results indicate that FLASH-RT protects normal lung tissue by regulating the immune microenvironment, inhibiting oxidative stress, reducing epithelial cell apoptosis, and maintaining mitochondrial function. In tumors, a differential molecular response occurs, involving activation of autophagy/apoptosis pathways, enhancement of cellular stress responses, disruption of mitochondrial homeostasis to reduce ATP production, and regulation of the PI3K/Akt signaling pathway to induce cell cycle arrest and apoptosis. This work reveals the molecular mechanisms of FLASH-RT, providing a theoretical basis for its clinical application and advancing precision radiotherapy for cancer.
MeSH Terms
Animals; Mice; Single-Cell Analysis; Lung; Apoptosis; Lung Neoplasms; Mitochondria; Oxidative Stress; Cell Line, Tumor; Humans; Signal Transduction
같은 제1저자의 인용 많은 논문 (5)
- Discovery of novel and potent 2-aminopyrazine-based HPK1 inhibitors enhancing T-cell immunity against cancer.
- RASGEF1B suppresses hepatocellular carcinoma through the ALDH7A1/Betaine/SNAI1 metabolic‒epigenetic axis.
- Mitochondria Pathway Signature Predicts Prognosis and Therapeutic Response and Identifies REXO2 as a Crucial Regulator in Breast Cancer.
- The microbial metabolite I3A inhibits ferroptosis and the effectiveness of redox-based cancer therapy.
- Correction: Guo et al. Shikonin as a WT1 Inhibitor Promotes Promyeloid Leukemia Cell Differentiation. 2022, , 8264.